Company: MDCXW
Filing Date: 2025-06-30
Form Type: DEF 14A
Source: 0001062993-25-012273
Chunk: 54

Company: Medicus Pharma Ltd.
Filing Date: 2025-06-30
Form: DEF 14A
Chunk 54
---
 of the Board, including communications that the Company determines to be primarily commercial in nature, personal grievances, and materials that are patently offensive or otherwise inappropriate.

<div align='center'>43

EXECUTIVE OFFICERS</div>

The following table provides information with respect to our executive officers as of June 2, 2025:

| Name               |     | Age |     | Position                                        |
| Dr. Raza Bokhari   |     |  58 |     | Executive Chairman and Chief Executive Officer  |
| Carolyn Bonner     |     |  41 |     | President                                       |
| James Quinlan      |     |  61 |     | Chief Financial Officer                         |
| Andrew Smith(1)    |     |  57 |     | Chief Operating Officer                         |
| Dr. Edward Brennan |     |  65 |     | Chief Scientific Officer & Head of Research and 
 development ("R&D") Program                     |
| Dr. Faisal Mehmud  |     |  50 |     | Chief Medical Officer                           |

Appointment effective as of, on or about, June 30, 2025.

Biographical Information

The biography of Dr. Raza Bokhari can be found under "Proposal 2 - Election of Directors." The following is biographical information for our other executive officers:

Carolyn Bonner, President

Carolyn Bonner has served as our President since September 2023.

Ms. Bonner until recently was the President & CEO of Parkway Clinical Laboratories (2019 to 2023), a College of American pathologist (CAP), accredited diagnostic company, serving healthcare providers across the United States.

Ms. Bonner was the Director of Corporate Development at Building Beyond BRIC Investment Fund (2019 to 2023) where she was extensively involved in fundraising, marketing, and assisting with back-office operations from May 2009 to December 2011.

Previously Ms. Bonner was the Director of Business Development at Parkway Clinical Laboratories ("PCL"), where she delivered client guided customization of PCL services and creative corporate partnerships. Carolyn also simultaneously served as Director of Corporate Development for Rosetta Genomics, a publicly traded Israeli biotech company, the parent company of PCL, from July 2008 to May 2009.

Ms. Bonner started her career in 2006 as a sales executive at Lakewood Pathology (now called PLUS Diagnostics), which is owned and operated by Water Street Healthcare Partners, a Chicago based private equity fund